AI
By
Is Mayo Clinic’s NVIDIA Blackwell-Powered DGX SuperPOD the Next Leap in AI-Driven Clinical Innovation?
Key Highlights NVIDIA Blackwell Infrastructure: High-Performance Compute for Healthcare AIThe NVIDIA DGX SuperPOD system delivers state-of-the-art, scalable AI…
Is Aptitude’s $9M BARDA Partnership and Metrix Filovirus Panel the Breakthrough for Fast, Decentralized Detection of Ebolavirus and Marburgvirus?
Key Highlights BARDA Partnership Accelerates Filovirus Diagnostic InnovationAptitude’s second collaboration with BARDA brings $9 million in new federal…
Is Aidoc’s $150M Bet on CARE™ and aiOS™ Resetting the Future of Clinical AI for 100 Million Patients?
Key Highlights CARE™ Foundation Model Redefining Standards in Clinical AIAidoc’s CARE™ model—now backed by $150 million in new…
Can Mandolin’s $40M VC Boost End Insurance Delays and Accelerate Access to Specialty Medications? What This Means for AI in Healthcare Delivery
Key Highlights: AI-Driven Innovation Tackling a Complex Healthcare BarrierSpecialty medications for cancer and neurodegenerative diseases often require authorization…
Will Lilly’s AI Supercomputer with NVIDIA Become the Breakthrough That Redefines Competitive Timelines in Drug Development?
• Lilly partners with NVIDIA to build what it calls the most powerful AI supercomputer operated by a…
Could Merck’s USD 349M Collaboration with Variational AI and Its Enki™ Platform Mark a Turning Point for Generative-AI-Designed Small Molecules?
Key Highlights A Strategic Alliance Targeting Hard-to-Crack Therapeutic SpaceVariational AI announced a major collaboration with Merck to deploy…
